EMEA (Europe, Middle East and Africa) Biosimilar Drug Market Report 2018

February 2018 | 101 pages | ID: E1F71206D78EN
QYResearch

Abstracts

In this report, the EMEA Biosimilar Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Biosimilar Drug for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Biosimilar Drug market competition by top manufacturers/players, with Biosimilar Drug sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including

• CP Guojian Pharma
• Biotech Pharma
• Celgen Pharma
• Henlius

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Injection
• Tablets
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Ankylosing Spondylitis
• Tumor
• Rheumatoid Arthrtis
• Cardiovascular

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Biosimilar Drug Market Report 2018

1 BIOSIMILAR DRUG OVERVIEW

1.1 Product Overview and Scope of Biosimilar Drug
1.2 Classification of Biosimilar Drug
  1.2.1 EMEA Biosimilar Drug Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Biosimilar Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Injection
  1.2.4 Tablets
  1.2.5 Others
1.3 EMEA Biosimilar Drug Market by Application/End Users
  1.3.1 EMEA Biosimilar Drug Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Ankylosing Spondylitis
  1.3.3 Tumor
  1.3.4 Rheumatoid Arthrtis
  1.3.5 Cardiovascular
1.4 EMEA Biosimilar Drug Market by Region
  1.4.1 EMEA Biosimilar Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Biosimilar Drug (2013-2025)
  1.5.1 EMEA Biosimilar Drug Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Biosimilar Drug Revenue and Growth Rate (2013-2025)

2 EMEA BIOSIMILAR DRUG COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Biosimilar Drug Market Competition by Players/Manufacturers
  2.1.1 EMEA Biosimilar Drug Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Biosimilar Drug Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Biosimilar Drug Sale Price by Players (2013-2018)
2.2 EMEA Biosimilar Drug (Volume and Value) by Type/Product Category
  2.2.1 EMEA Biosimilar Drug Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Biosimilar Drug Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Biosimilar Drug Sale Price by Type (2013-2018)
2.3 EMEA Biosimilar Drug (Volume) by Application
2.4 EMEA Biosimilar Drug (Volume and Value) by Region
  2.4.1 EMEA Biosimilar Drug Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Biosimilar Drug Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Biosimilar Drug Sales Price by Region (2013-2018)

3 EUROPE BIOSIMILAR DRUG (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Biosimilar Drug Sales and Value (2013-2018)
  3.1.1 Europe Biosimilar Drug Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Biosimilar Drug Revenue and Growth Rate (2013-2018)
3.2 Europe Biosimilar Drug Sales and Market Share by Type
3.3 Europe Biosimilar Drug Sales and Market Share by Application
3.4 Europe Biosimilar Drug Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Biosimilar Drug Sales Volume by Countries (2013-2018)
  3.4.2 Europe Biosimilar Drug Revenue by Countries (2013-2018)
  3.4.3 Germany Biosimilar Drug Sales and Growth Rate (2013-2018)
  3.4.4 France Biosimilar Drug Sales and Growth Rate (2013-2018)
  3.4.5 UK Biosimilar Drug Sales and Growth Rate (2013-2018)
  3.4.6 Russia Biosimilar Drug Sales and Growth Rate (2013-2018)
  3.4.7 Italy Biosimilar Drug Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Biosimilar Drug Sales and Growth Rate (2013-2018)

4 MIDDLE EAST BIOSIMILAR DRUG (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Biosimilar Drug Sales and Value (2013-2018)
  4.1.1 Middle East Biosimilar Drug Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Biosimilar Drug Revenue and Growth Rate (2013-2018)
4.2 Middle East Biosimilar Drug Sales and Market Share by Type
4.3 Middle East Biosimilar Drug Sales and Market Share by Application
4.4 Middle East Biosimilar Drug Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Biosimilar Drug Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Biosimilar Drug Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Biosimilar Drug Sales and Growth Rate (2013-2018)
  4.4.4 Israel Biosimilar Drug Sales and Growth Rate (2013-2018)
  4.4.5 UAE Biosimilar Drug Sales and Growth Rate (2013-2018)
  4.4.6 Iran Biosimilar Drug Sales and Growth Rate (2013-2018)

5 AFRICA BIOSIMILAR DRUG (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Biosimilar Drug Sales and Value (2013-2018)
  5.1.1 Africa Biosimilar Drug Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Biosimilar Drug Revenue and Growth Rate (2013-2018)
5.2 Africa Biosimilar Drug Sales and Market Share by Type
5.3 Africa Biosimilar Drug Sales and Market Share by Application
5.4 Africa Biosimilar Drug Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Biosimilar Drug Sales Volume by Countries (2013-2018)
  5.4.2 Africa Biosimilar Drug Revenue by Countries (2013-2018)
  5.4.3 South Africa Biosimilar Drug Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Biosimilar Drug Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Biosimilar Drug Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Biosimilar Drug Sales and Growth Rate (2013-2018)

6 EMEA BIOSIMILAR DRUG MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 CP Guojian Pharma
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Biosimilar Drug Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Biotech Pharma
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Biosimilar Drug Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Celgen Pharma
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Biosimilar Drug Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Celgen Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Henlius
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Biosimilar Drug Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Henlius Biosimilar Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview

7 BIOSIMILAR DRUG MANUFACTURING COST ANALYSIS

7.1 Biosimilar Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biosimilar Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Biosimilar Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA BIOSIMILAR DRUG MARKET FORECAST (2018-2025)

11.1 EMEA Biosimilar Drug Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Biosimilar Drug Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Biosimilar Drug Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Biosimilar Drug Price and Trend Forecast (2018-2025)
11.2 EMEA Biosimilar Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Biosimilar Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Biosimilar Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Biosimilar Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Biosimilar Drug Sales Forecast by Type (2018-2025)
11.7 EMEA Biosimilar Drug Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Biosimilar Drug
Figure EMEA Biosimilar Drug Sales Volume (K MT) by Type (2013-2025)
Figure EMEA Biosimilar Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure Injection Product Picture
Figure Tablets Product Picture
Figure Others Product Picture
Figure EMEA Biosimilar Drug Sales Volume (K MT) by Application (2013-2025)
Figure EMEA Sales Market Share of Biosimilar Drug by Application in 2017
Figure Ankylosing Spondylitis Examples
Table Key Downstream Customer in Ankylosing Spondylitis
Figure Tumor Examples
Table Key Downstream Customer in Tumor
Figure Rheumatoid Arthrtis Examples
Table Key Downstream Customer in Rheumatoid Arthrtis
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure EMEA Biosimilar Drug Market Size (Million USD) by Region (2013-2025)
Figure Europe Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Biosimilar Drug Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Biosimilar Drug Revenue (Million USD) Status and Forecast by Countries
Figure Africa Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Biosimilar Drug Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Biosimilar Drug Sales Volume and Growth Rate (2013-2025)
Figure EMEA Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Biosimilar Drug Market Major Players Product Sales Volume (K MT) (2013-2018)
Table EMEA Biosimilar Drug Sales Volume (K MT) of Major Players (2013-2018)
Table EMEA Biosimilar Drug Sales Share by Players (2013-2018)
Figure 2017 Biosimilar Drug Sales Share by Players
Figure 2017 Biosimilar Drug Sales Share by Players
Figure EMEA Biosimilar Drug Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Biosimilar Drug Revenue (Million USD) by Players (2013-2018)
Table EMEA Biosimilar Drug Revenue Share by Players (2013-2018)
Table 2017 EMEA Biosimilar Drug Revenue Share by Players
Table 2017 EMEA Biosimilar Drug Revenue Share by Players
Table EMEA Biosimilar Drug Sale Price (USD/MT) by Players (2013-2018)
Table EMEA Biosimilar Drug Sales (K MT) and Market Share by Type (2013-2018)
Table EMEA Biosimilar Drug Sales Share by Type (2013-2018)
Figure Sales Market Share of Biosimilar Drug by Type (2013-2018)
Figure EMEA Biosimilar Drug Sales Market Share by Type (2013-2018)
Table EMEA Biosimilar Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Biosimilar Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Biosimilar Drug by Type in 2017
Table EMEA Biosimilar Drug Sale Price (USD/MT) by Type (2013-2018)
Table EMEA Biosimilar Drug Sales (K MT) and Market Share by Application (2013-2018)
Table EMEA Biosimilar Drug Sales Share by Application (2013-2018)
Figure Sales Market Share of Biosimilar Drug by Application (2013-2018)
Figure EMEA Biosimilar Drug Sales Market Share by Application in 2017
Table EMEA Biosimilar Drug Sales (K MT) and Market Share by Region (2013-2018)
Table EMEA Biosimilar Drug Sales Share by Region (2013-2018)
Figure Sales Market Share of Biosimilar Drug by Region (2013-2018)
Figure EMEA Biosimilar Drug Sales Market Share in 2017
Table EMEA Biosimilar Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Biosimilar Drug Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Biosimilar Drug by Region (2013-2018)
Figure EMEA Biosimilar Drug Revenue Market Share Regions in 2017
Table EMEA Biosimilar Drug Sales Price (USD/MT) by Region (2013-2018)
Figure Europe Biosimilar Drug Sales (K MT) and Growth Rate (2013-2018)
Figure Europe Biosimilar Drug Revenue and Growth Rate (2013-2018)
Table Europe Biosimilar Drug Sales (K MT) by Type (2013-2018)
Table Europe Biosimilar Drug Market Share by Type (2013-2018)
Figure Europe Biosimilar Drug Market Share by Type in 2017
Table Europe Biosimilar Drug Sales (K MT) by Application (2013-2018)
Table Europe Biosimilar Drug Market Share by Application (2013-2018)
Figure Europe Biosimilar Drug Market Share by Application in 2017
Table Europe Biosimilar Drug Sales (K MT) by Countries (2013-2018)
Table Europe Biosimilar Drug Sales Market Share by Countries (2013-2018)
Figure Europe Biosimilar Drug Sales Market Share by Countries (2013-2018)
Figure Europe Biosimilar Drug Sales Market Share by Countries in 2017
Table Europe Biosimilar Drug Revenue (Million USD) by Countries (2013-2018)
Table Europe Biosimilar Drug Revenue Market Share by Countries (2013-2018)
Figure Europe Biosimilar Drug Revenue Market Share by Countries (2013-2018)
Figure Europe Biosimilar Drug Revenue Market Share by Countries in 2017
Figure Germany Biosimilar Drug Sales (K MT) and Growth Rate (2013-2018)
Figure France Biosimilar Drug Sales (K MT) and Growth Rate (2013-2018)
Figure UK Biosimilar Drug Sales (K MT) and Growth Rate (2013-2018)
Figure Russia Biosimilar Drug Sales (K MT) and Growth Rate (2013-2018)
Figure Italy Biosimilar Drug Sales (K MT) and Growth Rate (2013-2018)
Figure Benelux Biosimilar Drug Sales (K MT) and Growth Rate (2013-2018)
Figure Middle East Biosimilar Drug Sales (K MT) and Growth Rate (2013-2018)
Figure Middle East Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Biosimilar Drug Sales (K MT) by Type (2013-2018)
Table Middle East Biosimilar Drug Market Share by Type (2013-2018)
Figure Middle East Biosimilar Drug Market Share by Type (2013-2018)
Table Middle East Biosimilar Drug Sales (K MT) by Applications (2013-2018)
Table Middle East Biosimilar Drug Market Share by Applications (2013-2018)
Figure Middle East Biosimilar Drug Sales Market Share by Application in 2017
Table Middle East Biosimilar Drug Sales Volume (K MT) by Countries (2013-2018)
Table Middle East Biosimilar Drug Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Biosimilar Drug Sales Volume Market Share by Countries in 2017
Table Middle East Biosimilar Drug Revenue (Million USD) by Countries (2013-2018)
Table Middle East Biosimilar Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East Biosimilar Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East Biosimilar Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia Biosimilar Drug Sales (K MT) and Growth Rate (2013-2018)
Figure Israel Biosimilar Drug Sales (K MT) and Growth Rate (2013-2018)
Figure UAE Biosimilar Drug Sales (K MT) and Growth Rate (2013-2018)
Figure Iran Biosimilar Drug Sales (K MT) and Growth Rate (2013-2018)
Figure Africa Biosimilar Drug Sales (K MT) and Growth Rate (2013-2018)
Figure Africa Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Biosimilar Drug Sales (K MT) by Type (2013-2018)
Table Africa Biosimilar Drug Sales Market Share by Type (2013-2018)
Figure Africa Biosimilar Drug Sales Market Share by Type (2013-2018)
Figure Africa Biosimilar Drug Sales Market Share by Type in 2017
Table Africa Biosimilar Drug Sales (K MT) by Application (2013-2018)
Table Africa Biosimilar Drug Sales Market Share by Application (2013-2018)
Figure Africa Biosimilar Drug Sales Market Share by Application (2013-2018)
Table Africa Biosimilar Drug Sales Volume (K MT) by Countries (2013-2018)
Table Africa Biosimilar Drug Sales Market Share by Countries (2013-2018)
Figure Africa Biosimilar Drug Sales Market Share by Countries (2013-2018)
Figure Africa Biosimilar Drug Sales Market Share by Countries in 2017
Table Africa Biosimilar Drug Revenue (Million USD) by Countries (2013-2018)
Table Africa Biosimilar Drug Revenue Market Share by Countries (2013-2018)
Figure Africa Biosimilar Drug Revenue Market Share by Countries (2013-2018)
Figure Africa Biosimilar Drug Revenue Market Share by Countries in 2017
Figure South Africa Biosimilar Drug Sales (K MT) and Growth Rate (2013-2018)
Figure Nigeria Biosimilar Drug Sales (K MT) and Growth Rate (2013-2018)
Figure Egypt Biosimilar Drug Sales (K MT) and Growth Rate (2013-2018)
Figure Algeria Biosimilar Drug Sales (K MT) and Growth Rate (2013-2018)
Table CP Guojian Pharma Biosimilar Drug Basic Information List
Table CP Guojian Pharma Biosimilar Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure CP Guojian Pharma Biosimilar Drug Sales (K MT) and Growth Rate (2013-2018)
Figure CP Guojian Pharma Biosimilar Drug Sales Market Share in EMEA (2013-2018)
Figure CP Guojian Pharma Biosimilar Drug Revenue Market Share in EMEA (2013-2018)
Table Biotech Pharma Biosimilar Drug Basic Information List
Table Biotech Pharma Biosimilar Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Biotech Pharma Biosimilar Drug Sales (K MT) and Growth Rate (2013-2018)
Figure Biotech Pharma Biosimilar Drug Sales Market Share in EMEA (2013-2018)
Figure Biotech Pharma Biosimilar Drug Revenue Market Share in EMEA (2013-2018)
Table Celgen Pharma Biosimilar Drug Basic Information List
Table Celgen Pharma Biosimilar Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Celgen Pharma Biosimilar Drug Sales (K MT) and Growth Rate (2013-2018)
Figure Celgen Pharma Biosimilar Drug Sales Market Share in EMEA (2013-2018)
Figure Celgen Pharma Biosimilar Drug Revenue Market Share in EMEA (2013-2018)
Table Henlius Biosimilar Drug Basic Information List
Table Henlius Biosimilar Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Henlius Biosimilar Drug Sales (K MT) and Growth Rate (2013-2018)
Figure Henlius Biosimilar Drug Sales Market Share in EMEA (2013-2018)
Figure Henlius Biosimilar Drug Revenue Market Share in EMEA (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Drug
Figure Manufacturing Process Analysis of Biosimilar Drug
Figure Biosimilar Drug Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2017
Table Major Buyers of Biosimilar Drug
Table Distributors/Traders List
Figure EMEA Biosimilar Drug Sales (K MT) and Growth Rate Forecast (2018-2025)
Figure EMEA Biosimilar Drug Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Biosimilar Drug Price (USD/MT) and Trend Forecast (2018-2025)
Table EMEA Biosimilar Drug Sales (K MT) Forecast by Region (2018-2025)
Figure EMEA Biosimilar Drug Sales Market Share Forecast by Region (2018-2025)
Table EMEA Biosimilar Drug Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Biosimilar Drug Revenue Market Share Forecast by Region (2018-2025)
Table Europe Biosimilar Drug Sales (K MT) Forecast by Countries (2018-2025)
Figure Europe Biosimilar Drug Sales Market Share Forecast by Countries (2018-2025)
Table Europe Biosimilar Drug Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Biosimilar Drug Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Biosimilar Drug Sales (K MT) Forecast by Countries (2018-2025)
Figure Middle East Biosimilar Drug Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Biosimilar Drug Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Biosimilar Drug Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Biosimilar Drug Sales (K MT) Forecast by Countries (2018-2025)
Figure Africa Biosimilar Drug Sales Market Share Forecast by Countries (2018-2025)
Table Africa Biosimilar Drug Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Biosimilar Drug Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Biosimilar Drug Sales (K MT) Forecast by Type (2018-2025)
Figure EMEA Biosimilar Drug Sales Market Share Forecast by Type (2018-2025)
Table EMEA Biosimilar Drug Sales (K MT) Forecast by Application (2018-2025)
Figure EMEA Biosimilar Drug Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources